Jay Matushak Sells 4,448 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUE) CFO Jay Matushak sold 4,448 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the sale, the chief financial officer now owns 41,592 shares of the company’s stock, valued at $280,330.08. This trade represents a 9.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jay Matushak also recently made the following trade(s):

• On Tuesday, March 11th, Jay Matushak sold 814 shares of NeueHealth stock. The stock was sold at an average price of $6.85, for a total value of $5,575.90.
• On Friday, March 7th, Jay Matushak sold 1,860 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $13,373.40.
• On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $36,430.10.

NeueHealth Stock Performance

NYSE NEUE opened at $5.10 on Wednesday. The stock has a market capitalization of $42.25 million, a P/E ratio of -0.10 and a beta of 0.56. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $7.66. The business’s fifty day moving average is $7.16 and its two-hundred day moving average is $6.01.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of NEUE. Virtu Financial LLC bought a new position in shares of NeueHealth in the fourth quarter valued at $76,000. Northern Trust Corp raised its stake in NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after purchasing an additional 13,074 shares during the period. Finally, Partners Group Holding AG acquired a new stake in NeueHealth during the 3rd quarter valued at $463,000. Institutional investors own 63.88% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada dropped their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.